UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Endowment

Position in RNTX — Rein Therapeutics, Inc.

CIK 1019231 AUSTIN, TX

Position in RNTX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$532,074

-$133,019 QoQ

Shares Held

511,610

0.0% QoQ

Ownership

0.593%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#15

of 59 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $14,630,603 across 16 Biotechnology names. RNTX ranks #5 (3.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMTX	Immatics N.V.	697,431	$7,064,976
2	BBIO	BridgeBio Pharma, Inc.	32,838	$2,445,774
3	BMRN	Biomarin Pharmaceutical Inc	33,065	$1,891,979
4	ANRO	Alto Neuroscience, Inc.	22,175	$585,198
5	RNTX	Rein Therapeutics, Inc. This page	511,610	$532,074
6	PRAX	Praxis Precision Medicines, Inc.	1,525	$510,554
7	COGT	Cogent Biosciences, Inc.	7,488	$289,785
8	CELC	Celcuity Inc.	2,706	$283,101

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$532,074	511,610	0.0%	Shares	Sole	2026-08-03
2026-03-31	$665,093	511,610	0.0%	Shares	Sole	2026-05-07
2025-12-31	$593,467	511,610	0.0%	Shares	Sole	2026-02-17
2025-09-30	$585,793	511,610	0.0%	Shares	Sole	2025-11-13
2025-06-30	$716,254	511,610	0.0%	Shares	Sole	2025-07-31
2025-03-31	$905,549	511,610	-17.1%	Shares	Sole	2025-05-07
2024-12-31	$1,419,378	617,121	-56.0%	Shares	Sole	2025-02-19
2024-09-30	$4,967,820	1,403,339	-21.1%	Shares	Sole	2024-11-13
2024-06-30	$4,924,580	1,777,827	—	Shares	Sole	2024-09-17
No filing history on record for this holder in this stock.